202 related articles for article (PubMed ID: 33682630)
1. New ribotype
Gu W; Wang W; Li W; Li N; Wang Y; Zhang W; Lu C; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
Emerg Microbes Infect; 2021 Dec; 10(1):687-699. PubMed ID: 33682630
[No Abstract] [Full Text] [Related]
2. Characterization of Flagellum and Toxin Phase Variation in Clostridioides difficile Ribotype 012 Isolates.
Anjuwon-Foster BR; Maldonado-Vazquez N; Tamayo R
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735765
[No Abstract] [Full Text] [Related]
3. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
[TBL] [Abstract][Full Text] [Related]
4. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.
Carlson PE; Walk ST; Bourgis AE; Liu MW; Kopliku F; Lo E; Young VB; Aronoff DM; Hanna PC
Anaerobe; 2013 Dec; 24():109-16. PubMed ID: 23608205
[TBL] [Abstract][Full Text] [Related]
5. A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated
Dingle KE; Didelot X; Quan TP; Eyre DW; Stoesser N; Marwick CA; Coia J; Brown D; Buchanan S; Ijaz UZ; Goswami C; Douce G; Fawley WN; Wilcox MH; Peto TEA; Walker AS; Crook DW
mBio; 2019 Mar; 10(2):. PubMed ID: 30862754
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea.
Li C; Harmanus C; Zhu D; Meng X; Wang S; Duan J; Liu S; Fu C; Zhou P; Liu R; Wu A; Kuijper EJ; Smits WK; Fu L; Sun X
Emerg Microbes Infect; 2018 Dec; 7(1):211. PubMed ID: 30542069
[TBL] [Abstract][Full Text] [Related]
7. A genetic switch controls the production of flagella and toxins in Clostridium difficile.
Anjuwon-Foster BR; Tamayo R
PLoS Genet; 2017 Mar; 13(3):e1006701. PubMed ID: 28346491
[TBL] [Abstract][Full Text] [Related]
8. Genomic evolution and virulence association of
Xu X; Luo Y; Chen H; Song X; Bian Q; Wang X; Liang Q; Zhao J; Li C; Song G; Yang J; Sun L; Jiang J; Wang H; Zhu B; Ye G; Chen L; Tang YW; Jin D
Emerg Microbes Infect; 2021 Dec; 10(1):1331-1345. PubMed ID: 34125660
[No Abstract] [Full Text] [Related]
9. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
Sirard S; Valiquette L; Fortier LC
J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong.
Cheng VC; Yam WC; Lam OT; Tsang JL; Tse EY; Siu GK; Chan JF; Tse H; To KK; Tai JW; Ho PL; Yuen KY
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1371-81. PubMed ID: 21468685
[TBL] [Abstract][Full Text] [Related]
11. Flagellum and toxin phase variation impacts intestinal colonization and disease development in a mouse model of
Trzilova D; Warren MAH; Gadda NC; Williams CL; Tamayo R
Gut Microbes; 2022; 14(1):2038854. PubMed ID: 35192433
[No Abstract] [Full Text] [Related]
12. Rho factor mediates flagellum and toxin phase variation and impacts virulence in Clostridioides difficile.
Trzilova D; Anjuwon-Foster BR; Torres Rivera D; Tamayo R
PLoS Pathog; 2020 Aug; 16(8):e1008708. PubMed ID: 32785266
[TBL] [Abstract][Full Text] [Related]
13. Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.
Du P; Cao B; Wang J; Li W; Jia H; Zhang W; Lu J; Li Z; Yu H; Chen C; Cheng Y
J Clin Microbiol; 2014 Sep; 52(9):3264-70. PubMed ID: 24958798
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil.
Diniz AN; Moura LNF; Cruz DSG; Oliveira Junior CA; Figueiredo HCP; Cunha JLR; Vilela EG; Kuijper EJ; Wilcox MH; Lobato FCF; Silva ROS
PLoS One; 2022; 17(8):e0273013. PubMed ID: 36026500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile.
Vohra P; Poxton IR
Microbiology (Reading); 2011 May; 157(Pt 5):1343-1353. PubMed ID: 21330434
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of Clostridium difficile ST81, a new PCR ribotype of toxin A- B+ strain with high-level fluoroquinolones resistance and higher sporulation ability than ST37/PCR ribotype 017.
Wang B; Peng W; Zhang P; Su J
FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30085003
[TBL] [Abstract][Full Text] [Related]
17. A Revised Understanding of Clostridioides difficile Spore Germination.
Lawler AJ; Lambert PA; Worthington T
Trends Microbiol; 2020 Sep; 28(9):744-752. PubMed ID: 32781028
[TBL] [Abstract][Full Text] [Related]
18. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
19. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
[TBL] [Abstract][Full Text] [Related]
20. Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.
Edwards AN; Krall EG; McBride SM
J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31659010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]